Approaching a damages calculation on a cross-undertaking
AstraZeneca AB & Anor v KRKA, d.d Novo Mesto and Consilient Health Ltd  EWHC 84 (Pat) relates to an application for payment of damages, further to a cross-undertaking on a preliminary injunction. The preliminary injunction in question had been ordered against Consilient in 2010, preventing it from marketing its own-brand proton pump inhibitor (PPI), Emozul. The injunction was obtained on the basis of the patent protecting AstraZeneca’s PPI product, Nexium.
However, AstraZeneca later lost a related infringement action against Ranbaxy on this patent and, as a result, concluded that it could not win at trial against Consilient. Hence, AstraZeneca applied to have the injunction discharged…
Click on the link below to read the rest of the Taylor Wessing briefing.
News from Taylor Wessing
News from The Lawyer
Briefings from Taylor Wessing
Insolvency proceedings were opened in respect of the assets of a German resident; the liquidator then sought to set aside a transaction that had been entered into with a resident of Switzerland.
As of 1 October 2012, transfers of majority shares in a private limited liability company in Slovakia have become more complicated.
Analysis from The Lawyer
The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world
Financial disputes are starting to dominate the English courts as the long-awaited fallout from the downturn finally comes to town